Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss
The Laryngoscope · 2026
DOI: 10.1002/lary.70371 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Laryngoscope, 2026. Verfasst von Changshuo Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Audiology and Vestibular Medicine, Senior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology,…. Hauptthemen laut MEDLINE: Hearing Loss, Sensorineural, Hearing Loss, Sudden. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To identify prognostic factors for unilateral idiopathic sudden sensorineural hearing loss (SSNHL) in pediatric and adult patients, and to compare therapeutic efficacy between these age groups: Methods This retrospective cohort study included 1947 hospitalized patients (219 pediatric, 1728 adult) with unilateral idiopathic SSNHL from January 2008 to December 2022. All patients received inpatient therapy following the Chinese Guidelines for SSNHL, with pediatric dosing adjusted for age and weight. To compare therapeutic outcomes, multivariable logistic regression, full propensity score matching (PSM), restricted cubic spline (RCS), and machine learning algorithms were employed.
Results
Baseline median ages were 13 (IQR, 10–15) years for pediatric and 43 (IQR, 33–50) years for adult patients. Shared independent prognostic factors in both groups included audiogram configuration, degree of hearing loss, and treatment‐onset time. Furthermore, after matching, pediatric and adult patients had comparable complete recovery (18.7% vs. 16.4%) and overall efficacy rates (52.5% vs. 54.1%). The therapeutic window was identified as 14 days for children and 15 days for adults. Consistent with this, treatment‐onset time emerged as the most influential feature in predictive models, with pediatric outcomes achieving an area under the curve (AUC) of 0.849 and adult outcomes an AUC of 0.901.
Conclusions
Pediatric and adult patients with unilateral idiopathic SSNHL share major prognostic factors. Therapeutic efficacy is comparable between groups when appropriate treatment is provided. Early intervention, ideally within 2 weeks of symptom onset, is critical to maximize auditory recovery. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Audiology and Vestibular Medicine, Senior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, Ch…
- National Clinical Research Center for Otolaryngologic Diseases, Beijing, China.
- Department of Hearing and Speech Rehabilitation, Binzhou Medical University, Yantai, China.
- Nankai University, School of Medicine, Tianjin, China.
ORCID-Profile: Qiuju Wang
Förderung
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Shan, C., Zhang, J., Zhou, X., Wu, X., Chen, G., Liu, C., Guan, J., Gao, Y., Wang, D., & Wang, Q. (2026). Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss. The Laryngoscope. https://doi.org/10.1002/lary.70371
Vancouver
Shan C, Zhang J, Zhou X, Wu X, Chen G, Liu C, et al. Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss. The Laryngoscope. 2026. doi:10.1002/lary.70371
BibTeX
@article{Shan2026,
author = {Shan, Changshuo and Zhang, Jiao and Zhou, Xin and Wu, Xiaonan and Chen, Guohui and Liu, Chunyan and Guan, Jing and Gao, Yun and Wang, Dayong and Wang, Qiuju},
title = {Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70371}
}
EUVIMED